1 / 3

India Generic Drugs Market Trends, Size, Competitive Analysis and Forecast 2020-

India generic drugs market is estimated to grow at a CAGR of nearly 9.5% during the forecast period. Some pivotal factors encouraging market growth include the rising incidences of chronic diseases and favorable government initiatives to increase the affordability of medicines.

Meenoo
Download Presentation

India Generic Drugs Market Trends, Size, Competitive Analysis and Forecast 2020-

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research India Generic Drugs Market, Size, Share, Analysis Report & Forecast to 2026 To Market: https://www.omrglobal.com/request-sample/india-generic-drugs-market Request a Sample of our Report on India Generic Drugs Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. India generic drugs market India generic drugs market is estimated to grow at a CAGR of nearly 9.5% during the forecast period. A significant rise in the incidences of chronic diseases is driving the demand for generic drugs in the country. The National Cancer Registry Programme estimates that there will be 13.9 lakh new cancer incidences reported in India in 2020, which is expected to rise to 15.7 lakh by 2025. This leads to increasing demand for generic drugs that are playing a crucial role in cancer treatment. For instance, in everyday practice, patients with early-stage breast cancer, and children suffering from acute lymphoblastic leukemia are treated and cured with generics. In cancer care, generic drugs are also significantly used in supportive care beyond chemotherapy. (Get 15% Discount on Buying this Report) A full Report of India Generic Drugs Market is Available at: https://www.omrglobal.com/industry- reports/india-generic-drugs-market The increasing prevalence of diabetes is also supporting to drive market growth. As per the International Diabetes Federation (IDF), the total cases of diabetes reported in adults in India was nearly 77 million in 2019. This leads to increasing demand for generic medicines for diabetes which include Tolazamide (Tolinase), Acetohexamide, and Glimepiride (Amaryl). Additionally, several generic equivalents of the drug metformin (earlier sold only as Glucophage XR or Glucophage) are now available. To Request a Sample of our Market: https://www.omrglobal.com/request-sample/india-generic-drugs-market Report on India Generic Drugs Scope of the India Generic Drugs Market Market Coverage •Market number available for 2019-2026 •Base year- 2019 •Forecast period- 2020-2026 •Segment Covered- By Application and Route of Administration •Competitive Landscape- Mylan N.V., Teva Pharmaceutical Industries Ltd., Lupin Ltd., Aurobindo Pharma Ltd., and Sun Pharmaceutical Industries Ltd. Recent Strategic Initiatives in the India Generic Drugs Market •In July 2020, Cipla declared the launch of its generic version of antiviral drug remdesivir, Cipremi, at $53.3 per 100 mg vial. This makes it among the lowest cost versions for COVID-19 treatment and Cipla is looking to deliver more than 80,000 vials within the first month. •In July 2020, Mylan launched a generic version of Remdesivir drug, Desrem, in India for treatment of COVID-19 patients. This drug will be available at a price of nearly $64.2 per 100 mg vial as against Hetero’s Covifor at nearly 72.2 per 100 mg vial and Cipla’s Cipremi costing nearly $53.3 per 100 mg vial. India Generic Drugs Market-Segmentation By Application •Cancer •CVD •Musculoskeletal Diseases •Infectious Diseases •Neurology

  3. •Diabetes •Others By Route of Administration •Oral •Topical •Injectable •Inhaler Company Profiles •Aurobindo Pharma Ltd. •Biocon Ltd. •Cadila Healthcare Ltd. (CHL) •Cipla Ltd. •Dr. Reddy's Laboratories Ltd. •Glenmark Pharmaceuticals Ltd. •Lupin Ltd. •Mylan N.V. •Sun Pharmaceutical Industries Ltd. •Teva Pharmaceutical Industries Ltd Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/india-generic-drugs-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related